Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.

person Yeon Hee Park Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea info_outline Yeon Hee Park, Kyung-Hun Lee, Gun Min Kim, Seok Yun Kang, Keun Seok Lee, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee Jun Kim, Hanjo Kim, Su-Jin Koh, Ji-Yeon Kim, Joohyuk Sohn, Sung-Bae Kim, Jin Seok Ahn, Seonwoo Kim, Hyun Cho, Kyung Hae Jung, Seock-Ah Im

Authors person Yeon Hee Park Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea info_outline Yeon Hee Park, Kyung-Hun Lee, Gun Min Kim, Seok Yun Kang, Keun Seok Lee, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee Jun Kim, Hanjo Kim, Su-Jin Koh, Ji-Yeon Kim, Joohyuk Sohn, Sung-Bae Kim, Jin Seok Ahn, Seonwoo Kim, Hyun Cho, Kyung Hae Jung, Seock-Ah Im Organizations Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea, Seoul National University Hospital, Seoul, N/S, South Korea, Yonsei Cancer Center, Seoul, N/S, South Korea, Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea, Department of Oncology, National Cancer Center, Goyang-Si, South Korea, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South), Department of Hematology-Oncology, School of Medicine, Ewha Womans University, Seoul, South Korea, Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea, Inha University Hospital, Incheon, South Korea, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea, Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital, Cheonan, South Korea, Ulsan University Hosp, University of Ulsan, Dong-Gu, South Korea, Samsung Medical Center, Seoul, South Korea, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, Samsung Medical Center, Gangnam-Gu, South Korea, LSK Global PS, Seoul, South Korea, Seoul National University Hospital, Seoul, South Korea Abstract Disclosures

Clinical